Loading organizations...
Loading organizations...
Biotechnology company developing biologic therapies for oncology and autoim
Clover Biopharmaceuticals has raised $306.8M across 4 funding rounds.
Clover Biopharmaceuticals has raised $306.8M in total across 4 funding rounds.
Clover Biopharmaceuticals has raised $306.8M in total across 4 funding rounds.
Clover Biopharmaceuticals's investors include Temasek Holdings, Tim Xiao, Guangyu Xu, Tianhe Life Sciences.
Clover Biopharmaceuticals has raised $306.8M across 4 funding rounds. Most recently, it raised $230.0M Series C in February 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Feb 23, 2021 | $230.0M Series C | Temasek Holdings | |
| Jun 8, 2020 | $24.0M Series B | ||
| Nov 28, 2019 | $43.3M Series B | Tim Xiao, Guangyu Xu | |
| Dec 14, 2017 | $9.5M Series A | Tianhe Life Sciences |